Associations of CFH polymorphisms and CFHR1-CFHR3 deletion with blood pressure and hypertension in chinese population

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Gan, Wei ^a   Wu, Johnna ^a   Lu, Ling ^a   Xiao, Xu ^b   Huang, Heng ^a   Wang, Fulong ^a   Zhu, Jingwen ^a   Sun, Liang ^a   Liu, Gang ^a   Pan, Yi ^a   Li, Huaixing ^a   Lin, Xu ^a   Chen, Yan ^a  

^a Chinese Academy of Sciences   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; COMPLEMENT FACTOR H;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CFH GENE; CHINESE; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE; GENE ACTIVITY; GENE CLUSTER; GENE DELETION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MALE; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BLOOD PROTEINS; C-REACTIVE PROTEIN; COHORT STUDIES; COMPLEMENT C3B INACTIVATOR PROTEINS; COMPLEMENT FACTOR H; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE DELETION;

EID: 84864348884     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042010     Document Type: Article

References (29)

1. Pauletto P, Rattazzi M, (2006) Inflammation and hypertension: the search for a link. Nephrol Dial Transplant 21: 850-853.
2. Engstrom G, Hedblad B, Berglund G, Janzon L, Lindgarde F, (2007) Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study. J Hum Hypertens 21: 276-282.
3. Engstrom G, Hedblad B, Janzon L, Lindgarde F, (2007) Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study. Eur J Cardiovasc Prev Rehabil 14: 392-397.
4. Hage FG, Oparil S, Xing D, Chen YF, McCrory MA, et al. (2010) C-reactive protein-mediated vascular injury requires complement. Arterioscler Thromb Vasc Biol 30: 1189-1195.
5. Magen E, Mishal J, Paskin J, Glick Z, Yosefy C, et al. (2008) Resistant arterial hypertension is associated with higher blood levels of complement C3 and C-reactive protein. J Clin Hypertens (Greenwich) 10: 677-683.
6. Magen E, Feldman A, Cohen Z, Alon DB, Linov L, et al. (2010) Potential link between C3a, C3b and endothelial progenitor cells in resistant hypertension. Am J Med Sci 339: 415-419.
7. Fritsche LG, Lauer N, Hartmann A, Stippa S, Keilhauer CN, et al. (2010) An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum Mol Genet 19: 4694-4704.
8. Okemefuna AI, Nan R, Miller A, Gor J, Perkins SJ, (2010) Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations. J Biol Chem 285: 1053-1065.
9. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
10. Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R, et al. (2006) CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38: 1049-1054.
11. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, et al. (2006) A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38: 1173-1177.
12. Arakawa S, Takahashi A, Ashikawa K, Hosono N, Aoi T, et al. (2011) Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Genet 43: 1001-1004.
13. Wright AF, (2011) A rare variant in CFH directly links age-related macular degeneration with rare glomerular nephropathies. Nat Genet 43: 1176-1177.
14. Laine M, Jarva H, Seitsonen S, Haapasalo K, Lehtinen MJ, et al. (2007) Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol 178: 3831-3836.
15. Robman L, Baird PN, Dimitrov PN, Richardson AJ, Guymer RH, (2010) C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression. Ophthalmology 117: 1982-1988.
16. Ye X, Yu Z, Li H, Franco OH, Liu Y, et al. (2007) Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 49: 1798-1805.
17. Cui JS, Hopper JL, Harrap SB, (2003) Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 41: 207-210.
18. Jiang S, Bao Y, Hou X, Fang Q, Wang C, et al. (2009) Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population. Am J Cardiol 103: 1727-1731.
19. Edwards AO, Ritter R, 3rd, Abel KJ, Manning A, Panhuysen C, et al (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
20. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232.
21. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
22. Raychaudhuri S, Ripke S, Li M, Neale BM, Fagerness J, et al. (2010) Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent. Nat Genet 42: 553-555; author reply 555-556.
23. Muscari A, Bozzoli C, Puddu GM, Sangiorgi Z, Dormi A, et al. (1995) Association of serum C3 levels with the risk of myocardial infarction. Am J Med 98: 357-364.
24. Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, et al. (2000) Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J 21: 1081-1090.
25. Nadar SK, Lip GY, (2007) New insights into complement C3 and inflammation in hypertension. J Hum Hypertens 21: 261-263.
26. Onat A, Can G, Rezvani R, Cianflone K, (2011) Complement C3 and cleavage products in cardiometabolic risk. Clin Chim Acta 412: 1171-1179.
27. Zipfel PF, Edey M, Heinen S, Jozsi M, Richter H, et al. (2007) Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet 3: e41.
28. Zhao J, Wu H, Khosravi M, Cui H, Qian X, et al. (2011) Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet 7: e1002079.
29. Sofat R, Casas JP, Kumari M, Talmud PJ, Ireland H, et al. (2010) Genetic variation in complement factor H and risk of coronary heart disease: eight new studies and a meta-analysis of around 48,000 individuals. Atherosclerosis 213: 184-190.